Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Other companies in Intellia Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX), Arrowhead Pharma (NASDAQ:ARWR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Intellia Therapeutics has a consensus price target of $81.36.
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $21.5438 last updated September 24, 2024 at 5:13 PM EDT.
There are no upcoming dividends for Intellia Therapeutics.
Intellia Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Intellia Therapeutics.
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.